Pasar al contenido principal

EL RECEPTOR CB1 CANNABINOIDE COMO POSIBLE NEXO MOLECULAR EN DISCAPACIDAD INTELECTUAL NO SINDROMICA

PID2021-125118OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2021
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD COMPLUTENSE DE MADRID

Resultados relacionados

Resultados totales (Incluyendo duplicados): 11
Encontrada(s) 1 página(s)

Docta Complutense
Publicación Artículo científico (JournalArticle)

CB1 receptors in NG2 cells mediate cannabinoid-evoked functional myelin regeneration

  • Sánchez De La Torre, Aníbal
  • Ezquerro Herce, Sara
  • Huerga Gómez, Alba
  • Sánchez Martín, Ester
  • Chara, Juan Carlos
  • Matute, Carlos
  • Monory, Krisztina
  • Mato, Susana
  • Lutz, Beat
  • Guzmán Pastor, Manuel
  • Aguado Sánchez, Tania
  • Palazuelos Diego, Javier
Defects in myelin homeostasis have been reported in many neuropathological conditions. Cannabinoid compounds have been shown to efficiently promote myelin regeneration in animal models of demyelination. However, it is still unknown whether this action relies mostly on a cell autonomous effect on oligodendroglial-lineage-NG2 cells. By using conditional genetic mouse models, here we found that cannabinoid CB1 receptors located on NG2 cells are required for oligodendroglial differentiation and myelin regeneration after demyelination. Selective CB1 receptor gene depletion in NG2 cells following toxin-induced demyelination disrupted oligodendrocyte regeneration and functional remyelination and exacerbated axonal damage. These deficits were rescued by pharmacological blockade of the RhoA/ROCK/Cofilin pathway. Conversely, tetrahydrocannabinol administration promoted oligodendrocyte regeneration and functional remyelination in wild-type but not Ng2-CB1-deficient mice. Overall, this study identifies CB1 receptors as essential modulators of remyelination and support the therapeutic potential of cannabinoids for promoting remyelination in neurological disorders.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Restoration of CB1 receptor function in hippocampal GABAergic neurons rescues memory deficits in Huntington's disease models

  • Franco, Nadia Di
  • Bengoetxea de Tena, Iker
  • Sanchez-Ruiz, Andrea
  • Pereda-Velarde, Alba
  • Enfedaque, Ferran
  • González-Arias, Candela
  • Miquel-Rio, Lluis
  • Bortolozzi, Analía
  • Rodríguez-Puertas, Rafael
  • Costas-Insua, Carlos
  • Molina-Porcel, Laura
  • Vázquez-Oliver, Anna
  • Ozaita Mintegui, Andrés, 1969-
  • Guzmán, Manuel
  • Perea, Gertrudis
  • Ginés, Silvia
Background: Dysregulation of the endocannabinoid system (eCBS) and the loss of CB1 receptors (CB1R) in the basal ganglia are well-established hallmarks of Huntington's disease (HD). As a result, significant research efforts have focused on targeting the eCBS to alleviate motor disturbances associated with the disease. Beyond its role in motor control, the eCBS is a complex signaling network critically involved in regulating learning and memory. Despite this, the potential involvement of eCBS dysfunction in the cognitive decline characteristic of HD, often manifested well before motor dysfunction, has remained largely unexplored. Methods: CB1R expression in the hippocampus was evaluated in both human HD samples and HD mouse models (R6/1 and Hdh models, including both sexes) using Western blotting, immunohistochemistry, and radioligand binding assays. To restore CB1R function, CB1R agonist WIN-55212-2 was systemically administered, or viral vectors encoding CB1R were locally infused into the hippocampus of HD mice. A multidisciplinary approach combining behavioral, biochemical, electrophysiological, and morphological analyses, was employed to investigate the molecular mechanisms underlying the effects of CB1R activation in the context of HD-related cognitive dysfunction. Results: In both human HD samples and HD mouse models, CB1R protein levels were reduced in the hippocampus, accompanied by structural synaptic alterations and impairment in spatial, recognition and working memory. Moreover, hippocampal depolarization-induced suppression of inhibition was significantly disrupted in R6/1 mice. Administration of WIN-55212-2 successfully restored these synaptic and cognitive deficits. Immunohistochemical analysis revealed that the CB1R decrease was specifically localized to GABAergic interneurons within the hippocampus. Notably, targeted restoration of CB1R expression in these interneurons via viral vector delivery was sufficient to rescue hippocampal-dependent memory deficits in HD mice. Conclusion: This study suggests that impaired CB1R function in hippocampal GABAergic interneurons contributes to memory dysfunction in HD., This work was supported by the Spanish Ministerio de Ciencia e Innovación (PID2021-123732OB-I00 to SG, PID2021-125118OB-I00 to MG, PID2019-106579RB-I00, and PID2022-142617NB-I00 to GP, and PID2022-141700OB-I00 to AB funded by MCIN/AEI/ https://doi.org/10.13039/501100011033). Fundació la Marató de TV3 (202013-30-31-32 to SG, MG and GP), AGAUR Generalitat de Catalunya (2021-SGR-01358 to AB and 2021-SGR 01086 to SG) and grants to R. R.-P. rom the Basque Government IT1454-22 to the "Neurochemistry and Neurodegeneration" consolidated research group; Instituto de Salud Carlos III through the project PI20/00153 (co-funded by European Regional Development Fund "A way to make Europe") and by BIOEF through the project BIO22/ALZ/010 funded by Eitb Maratoia. A P-V is the recipient of a PRE2022-101764 fellowship (PID2021-123732OB-I00). I.B.d.T. is the recipient of an Investigo fellowship funded by the European Union-Next Generation EU.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Neuronal cannabinoid CB1 receptors suppress the growth of melanoma brain metastases by inhibiting glutamatergic signalling

  • Costas-Insua, Carlos
  • Seijo-Vila, Marta
  • Blázquez, Cristina
  • Blasco-Benito, Sandra
  • Rodríguez-Baena, Francisco Javier
  • Marsicano, Giovanni
  • Pérez-Gómez, Eduardo
  • Sánchez, Cristina
  • Sánchez-Laorden, Berta
  • Guzmán, Manuel
This article belongs to the Special Issue Novel Insights into Glioblastoma and Brain Metastases., [Simple Summary] An estimated 60% of melanoma patients develop melanoma brain metastases (MBMs). However, the molecular factors that govern the growth of MBMs are still unknown. The excitatory neurotransmitter glutamate has been shown to control the proliferation of various types of cancer cells within the brain parenchyma, but the cellular sources and molecular mechanisms involved in this process remain unclear. By their well-known role in inhibiting synaptic glutamate release, cannabinoid CB1 receptors (CB1Rs) located on glutamatergic nerve terminals are conceivably well-positioned to control the growth of MBMs. In silico data mining in cancer-genome atlases and in vitro studies with melanoma cell lines supported that a glutamate-NMDA receptor axis drives melanoma cell proliferation. Strikingly, grafting melanoma cells into the brain of mice lacking CB1Rs selectively in glutamatergic neurons increased tumour size and concomitantly activated NMDA receptors on tumour cells. Altogether, our findings reveal an unprecedented role of neuronal CB1Rs in controlling MBMs., Melanoma is one of the deadliest forms of cancer. Most melanoma deaths are caused by distant metastases in several organs, especially the brain, the so-called melanoma brain metastases (MBMs). However, the precise mechanisms that sustain the growth of MBMs remain elusive. Recently, the excitatory neurotransmitter glutamate has been proposed as a brain-specific, pro-tumorigenic signal for various types of cancers, but how neuronal glutamate shuttling onto metastases is regulated remains unknown. Here, we show that the cannabinoid CB1 receptor (CB1R), a master regulator of glutamate output from nerve terminals, controls MBM proliferation. First, in silico transcriptomic analysis of cancer-genome atlases indicated an aberrant expression of glutamate receptors in human metastatic melanoma samples. Second, in vitro experiments conducted on three different melanoma cell lines showed that the selective blockade of glutamatergic NMDA receptors, but not AMPA or metabotropic receptors, reduces cell proliferation. Third, in vivo grafting of melanoma cells in the brain of mice selectively devoid of CB1Rs in glutamatergic neurons increased tumour cell proliferation in concert with NMDA receptor activation, whereas melanoma cell growth in other tissue locations was not affected. Taken together, our findings demonstrate an unprecedented regulatory role of neuronal CB1Rs in the MBM tumour microenvironment., This research was funded by the Spanish Ministerio de Ciencia e Innovación (MICIN; supported with European Regional Development (FEDER) funds; grant numbers PID2021-125118OB-I00 to M.G., PID2019-106852RB-I00 to B.S.-L., and PI17/00041 and PI20/00590 to C.S. and E.P.-G.) and by Fundación Canna (grant number 2023/0036 to M.G.). G.M. was supported by INSERM. C.C.-I. was supported by a contract from the Spanish Ministerio de Universidades (Formación de Profesorado Universitario Program, reference FPU16/02593). M.S.-V. was supported by a contract from Universidad Complutense de Madrid (Contratos Predoctorales UCM Program)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The CB 1 receptor interacts with cereblon and drives cereblon deficiency-associated memory shortfalls

  • Costas-Insua, Carlos
  • Hermoso-López, Alba
  • Moreno, Estefanía
  • Montero-Fernández, Carlos
  • Álvaro-Blázquez, Alicia
  • Maroto, Irene B.
  • Sánchez-Ruiz, Andrea
  • Diez-Alarcia, Rebeca
  • Blázquez, Cristina
  • Morales, Paula
  • Canela, Enric I.
  • Casadó, Vicent
  • Urigüen, Leyre
  • Perea, Gertrudis
  • Bellocchio, Luigi
  • Rodríguez-Crespo, Ignacio
  • Guzmán, Manuel
Cereblon/CRBN is a substrate-recognition component of the Cullin4A-DDB1-Roc1 E3 ubiquitin ligase complex. Destabilizing mutations in the human CRBN gene cause a form of autosomal recessive non-syndromic intellectual disability (ARNSID) that is modelled by knocking-out the mouse Crbn gene. A reduction in excitatory neurotransmission has been proposed as an underlying mechanism of the disease. However, the precise factors eliciting this impairment remain mostly unknown. Here we report that CRBN molecules selectively located on glutamatergic neurons are necessary for proper memory function. Combining various in vivo approaches, we show that the cannabinoid CB 1 receptor (CB 1 R), a key suppressor of synaptic transmission, is overactivated in CRBN deficiency-linked ARNSID mouse models, and that the memory deficits observed in these animals can be rescued by acute CB 1 R-selective pharmacological antagonism. Molecular studies demonstrated that CRBN interacts physically with CB 1 R and impairs the CB 1 R-G i/o -cAMP-PKA pathway in a ubiquitin ligase- independent manner. Taken together, these findings unveil that CB 1 R overactivation is a driving mechanism of CRBN deficiency- linked ARNSID and anticipate that the antagonism of CB 1 R could constitute a new therapy for this orphan disease., This work was supported by the Spanish Ministerio de Ciencia e Innovación (MICINN/FEDER; grants PID2021-125118OB-I00 to MG, PID2020-113938RB- I00 to EM and VC, PID2019-106579RB-I00 and PID2022-142617NB-I00 to GP, and PID2019-106404RB-I00 to LU), as well as by the Generalitat de Catalunya (grant 2021-SGR-00230 to EM and VC). LB was supported by INSERM. CC-I and IBM were supported by contracts from the Spanish Ministerio de Universidades (Formación de Profesorado Universitario Program, references FPU16/02593 and FPU15/01833, respectively). CC-I was also supported by an EMBO short-term fellowship (reference STF-8930). We are indebted to Dr. Benjamin L. Ebert for the kind donation of HEK-293T-CRBN-KO and parental HEK-293T-CRBN-WT cells. We also thank David Martín-Gutiérrez, Lucía Rivera-Endrinal, Dr. Daniel García-Ovejero, Dr. Eduardo Molina-Holgado, and the personnel of the core microscopy centre, the genomics unit, and the animal facilities of Universidad Complutense de Madrid for their expert technical assistance., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The CB1 receptor interacts with cereblon and drives cereblon deficiency-associated memory shortfalls

  • Costas-Insua, Carlos
  • Hermoso-López, Alba
  • Moreno, Estefanía
  • Diez-Alarcia, Rebeca
  • Álvaro-Blázquez, Alicia
  • Maroto, Irene B.
  • Sanchez-Ruiz, A.
  • Blázquez, Cristina
  • Morales, Paula
  • Canela, Enric I.
  • Casadó, Vicent
  • Urigüen, Leyre
  • Perea, Gertrudis
  • Bellocchio, Luigi
  • Rodríguez-Crespo, Ignacio
  • Guzmán, Manuel
Cereblon/CRBN is a substrate-recognition component of the Cullin4A-DDB1-Roc1 E3 ubiquitin ligase complex. Destabilizing mutations in the human CRBN gene cause a form of autosomal recessive non-syndromic intellectual disability (ARNSID) that is modelled by knocking-out the mouse Crbn gene. A reduction in excitatory neurotransmission has been proposed as an underlying mechanism of the disease. However, the precise factors eliciting this impairment remain mostly unknown. Here we report that CRBN molecules selectively located on glutamatergic neurons are necessary for proper memory function. Combining various in vivo approaches, we show that the cannabinoid CB1 receptor (CB1R), a key suppressor of synaptic transmission, is overactivated in CRBN deficiency-linked ARNSID mouse models, and that the memory deficits observed in these animals can be rescued by acute CB1R-selective pharmacological antagonism. Molecular studies demonstrated that CRBN interacts physically with CB1R and impairs the CB1R-Gi/o-cAMP-PKA pathway in a ubiquitin ligase-independent manner. Taken together, these findings unveil that CB1R overactivation is a driving mechanism of CRBN deficiency-linked ARNSID and anticipate that the antagonism of CB1R could constitute a new therapy for this orphan disease., This work was supported by the Spanish Ministerio de Ciencia e Innovación (MICINN/FEDER; grants PID2021-125118OB-I00 to MG, PID2020-113938RB-I00 to EM and VC, PID2019-106579RB-I00 and PID2022-142617NB-I00 to GP, and PID2019-106404RB-I00 to LU), as well as by the Generalitat de Catalunya (grant 2021-SGR-00230 to EM and VC). LB was supported by INSERM. CC-Iand IBM were supported by contracts from the Spanish Ministerio de Universidades (Formación de Profesorado Universitario Program, referencesFPU16/02593 and FPU15/01833, respectively). CC-I was also supported by an EMBO short-term fellowship (reference STF-8930). We are indebted to Dr.Benjamin L. Ebert for the kind donation of HEK-293T-CRBN-KO and parental HEK-293T-CRBN-WT cells. We also thank David Martín-Gutiérrez, Lucía Rivera-Endrinal, Dr. Daniel García-Ovejero, Dr. Eduardo Molina-Holgado, and the personnel of the core microscopy centre, the genomics unit, and the animal facilities of Universidad Complutense de Madrid for their expert technical assistance.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The CB1 receptor interacts with cereblon and drives cereblon deficiency-associated memory shortfalls

  • Costas-Insua, Carlos
  • Hermoso-López, Alba
  • Moreno, Estefanía
  • Montero-Fernández, Carlos
  • Álvaro-Blázquez, Alicia
  • Maroto, Irene B.
  • Sánchez-Ruiz, Andrea
  • Diez-Alarcia, Rebeca
  • Blázquez, Cristina
  • Morales, Paula
  • Canela, Enric I.
  • Casadó, Vicent
  • Urigüen, Leyre
  • Perea, Gertrudis
  • Bellocchio, Luigi
  • Rodríguez-Crespo, Ignacio
  • Guzmán, Manuel
Cereblon/CRBN is a substrate-recognition component of the Cullin4A-DDB1-Roc1 E3 ubiquitin ligase complex. Destabilizing mutations in the human CRBN gene cause a form of autosomal recessive non-syndromic intellectual disability (ARNSID) that is modelled by knocking-out the mouse Crbn gene. A reduction in excitatory neurotransmission has been proposed as an underlying mechanism of the disease. However, the precise factors eliciting this impairment remain mostly unknown. Here we report that CRBN molecules selectively located on glutamatergic neurons are necessary for proper memory function. Combining various in vivo approaches, we show that the cannabinoid CB1 receptor (CB1R), a key suppressor of synaptic transmission, is overactivated in CRBN deficiency-linked ARNSID mouse models, and that the memory deficits observed in these animals can be rescued by acute CB1R-selective pharmacological antagonism. Molecular studies demonstrated that CRBN interacts physically with CB1R and impairs the CB1R-Gi/o-cAMP-PKA pathway in a ubiquitin ligase-independent manner. Taken together, these findings unveil that CB1R overactivation is a driving mechanism of CRBN deficiency-linked ARNSID and anticipate that the antagonism of CB1R could constitute a new therapy for this orphan disease., This work was supported by the Spanish Ministerio de Ciencia e Innovación (MICINN/FEDER; grants PID2021-125118OB-I00 to MG, PID2020-113938RB-I00 to EM and VC, PID2019-106579RB-I00 and PID2022-142617NB-I00 to GP, and PID2019-106404RB-I00 to LU), as well as by the Generalitat de Catalunya (grant 2021-SGR-00230 to EM and VC). LB was supported by INSERM. CC-I and IBM were supported by contracts from the Spanish Ministerio de Universidades (Formación de Profesorado Universitario Program, references FPU16/02593 and FPU15/01833, respectively). CC-I was also supported by an EMBO short-term fellowship (reference STF-8930). We are indebted to Dr. Benjamin L. Ebert for the kind donation of HEK-293T-CRBN-KO and parental HEK-293T-CRBN-WT cells. We also thank David Martín-Gutiérrez, Lucía Rivera-Endrinal, Dr. Daniel García-Ovejero, Dr. Eduardo Molina-Holgado, and the personnel of the core microscopy centre, the genomics unit, and the animal facilities of Universidad Complutense de Madrid for their expert technical assistance., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Restoration of CB1 receptor function in hippocampal GABAergic neurons rescues memory deficits in Huntington's disease models

  • Di Franco, Nadia
  • Bengoetxea de Tena, Iker
  • Sanchez-Ruiz, Andrea
  • Pereda-Velarde, Alba
  • Enfedaque, Ferran
  • Gónzalez-Arias, Candela
  • Rio, Lluis Maria Miquel
  • Bortolozzi, Analía
  • Rodriguez-Puertas, Rafael
  • Costas-Insua, Carlos
  • Molina-Porcel, Laura
  • Vazquez-Oliver, Anna
  • Ozaita, Andres
  • Guzmán, Manuel
  • Perea, Gertrudis
  • Ginés, Silvia
Dysregulation of the endocannabinoid system (eCBS) and the loss of CB1 receptors (CB1R) in the basal ganglia are well-established hallmarks of Huntington's disease (HD). As a result, significant research efforts have focused on targeting the eCBS to alleviate motor disturbances associated with the disease. Beyond its role in motor control, the eCBS is a complex signaling network critically involved in regulating learning and memory. Despite this, the potential involvement of eCBS dysfunction in the cognitive decline characteristic of HD, often manifested well before motor dysfunction, has remained largely unexplored., This work was supported by the Spanish Ministerio de Ciencia e Innovación (PID2021-123732OB-I00 to SG, PID2021-125118OB-I00 to MG, PID2019-106579RB-I00, and PID2022-142617NB-I00 to GP, and PID2022-141700OB-I00 to AB funded by MCIN/AEI/ https://doi.org/10.13039/501100011033). Fundació la Marató de TV3 (202013-30-31–32 to SG, MG and GP), AGAUR Generalitat de Catalunya (2021-SGR-01358 to AB and 2021-SGR 01086 to SG) and grants to R. R.-P. from the Basque Government IT1454-22 to the “Neurochemistry and Neurodegeneration” consolidated research group; Instituto de Salud Carlos III through the project PI20/00153 (co-funded by European Regional Development Fund “A way to make Europe”) and by BIOEF through the project BIO22/ALZ/010 funded by Eitb Maratoia. A P-V is the recipient of a PRE2022-101764 fellowship (PID2021-123732OB-I00). I.B.d.T. is the recipient of an Investigo fellowship funded by the European Union-Next Generation EU., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Prenatal Downregulation of CB1 Cannabinoid Receptors in the Mouse Prefrontal Cortex Disrupts Cortical Lamination and Induces a Transcriptional Signature Associated with Social Interaction Deficits

  • Simón-Sánchez, Samuel
  • den Boon, Femke
  • García-Rincón, Daniel
  • Skrempou, Georgia
  • Paraíso-Luna, Juan
  • Aguilera, Alfonso
  • Nieto, Marta
  • Werkman, Taco R
  • Guzmán, Manuel
  • Chameau, Pascal
  • Galve-Roperh, Ismael
Endocannabinoid signaling exerts a neurodevelopmental regulatory role via CB1 cannabinoid receptors (CB1Rs), which control pyramidal neuron differentiation, migration, and axonal guidance. Here, we investigated the long-lasting consequences of transient prenatal CB1R downregulation within the mouse prefrontal cortex by assessing its impact on gene expression, neuronal electrophysiological properties, and animal behavioral traits. Transient loss of CB1Rs as induced by in-utero small-interference RNA electroporation at Embryonic Day 14.5, when upper-layer neurons are generated, arrested cell migration leading to ectopic neurons that populated deep layers. Whole-cell current-clamp recordings showed that ectopic neurons are less excitable (increased afterhyperpolarization amplitude, decreased sag, lower firing frequency) than deep-layer-native pyramidal neurons. Differentially expressed genes (DEGs), identified by microarray characterization of FACS-sorted electroporated neurons, were significantly enriched in pathways related to cortical development, regulation of cell migration, neurotransmitter secretion, and cytoskeletal organization. Gene set enrichment analysis also supported enrichment in pathways associated with neurodegenerative disorders and synaptic function. The gene expression profile of siCB1R-derived neurons showed DEGs that had been previously associated with intellectual disability, schizophrenia, and autism. Venn diagrams unveiled one common DEG for neuropsychiatric risk databases and CB1R expression manipulation, namely, the transcription factor ZBTB20. Prenatal knockdown of CB1Rs induced long-lasting behavioral alterations in the adult offspring of either sex, with an impairment of social interaction and motor behavior in siCB1R-derived adult mice. Taken together, these findings highlight the role of CB1Rs in controlling the development of pyramidal neurons in the prefrontal cortex and support the contribution of altered endocannabinoid signaling to neuropsychiatric vulnerability., This work was supported by the Instituto de Salud Carlos III and cofunded by the European Union (Grants PI21/00938 and PI18/00941 to I.G.-R.), the Spanish Ministerio de Ciencia, Innovación y Universidades (MICINN/FEDER; Grant PID2021-125118OB-I00 to M.G.), and the Dutch Epilepsy Fundation (EpilepsieNL, Grant WAR17_11 to T.R.W. and P.C.). S.S.-S., D.G.-R., and J.P.-L. were supported by Instituto de Salud Carlos III (PFIS), Fundación Tatiana Pérez de Guzmán, and the Spanish Ministerio de Ciencia, Innovación y Universidades (FPU Program), respectively. We are indebted to Alba Mérida, Franck Richard, Tania Aguado, Tania Gavaldá, Estrella Villanueva, Aníbal Sánchez, David van Oorschot, and Laila Kulsvehagen for their experimental assistance and data processing; to Héctor Montero and Eva Resel for their expert technical assistance and lab managing; and to Val Fernández (IRYCIS) for the bioinformatics guidance., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Restoration of CB1 receptor function in hippocampal GABAergic neurons rescues memory deficits in Huntington's disease models

  • Franco, Nadia Di
  • Bengoetxea de Tena, Iker
  • Sanchez-Ruiz, Andrea
  • Pereda-Velarde, Alba
  • Enfedaque, Ferran
  • González-Arias, Candela
  • Miquel-Rio, Lluis
  • Bortolozzi, Analía
  • Rodríguez-Puertas, Rafael
  • Costas-Insua, Carlos
  • Molina-Porcel, Laura
  • Vázquez-Oliver, Anna
  • Ozaita Mintegui, Andrés, 1969-
  • Guzmán, Manuel
  • Perea, Gertrudis
  • Ginés, Silvia
Background: Dysregulation of the endocannabinoid system (eCBS) and the loss of CB1 receptors (CB1R) in the basal ganglia are well-established hallmarks of Huntington's disease (HD). As a result, significant research efforts have focused on targeting the eCBS to alleviate motor disturbances associated with the disease. Beyond its role in motor control, the eCBS is a complex signaling network critically involved in regulating learning and memory. Despite this, the potential involvement of eCBS dysfunction in the cognitive decline characteristic of HD, often manifested well before motor dysfunction, has remained largely unexplored. Methods: CB1R expression in the hippocampus was evaluated in both human HD samples and HD mouse models (R6/1 and Hdh models, including both sexes) using Western blotting, immunohistochemistry, and radioligand binding assays. To restore CB1R function, CB1R agonist WIN-55212-2 was systemically administered, or viral vectors encoding CB1R were locally infused into the hippocampus of HD mice. A multidisciplinary approach combining behavioral, biochemical, electrophysiological, and morphological analyses, was employed to investigate the molecular mechanisms underlying the effects of CB1R activation in the context of HD-related cognitive dysfunction. Results: In both human HD samples and HD mouse models, CB1R protein levels were reduced in the hippocampus, accompanied by structural synaptic alterations and impairment in spatial, recognition and working memory. Moreover, hippocampal depolarization-induced suppression of inhibition was significantly disrupted in R6/1 mice. Administration of WIN-55212-2 successfully restored these synaptic and cognitive deficits. Immunohistochemical analysis revealed that the CB1R decrease was specifically localized to GABAergic interneurons within the hippocampus. Notably, targeted restoration of CB1R expression in these interneurons via viral vector delivery was sufficient to rescue hippocampal-dependent memory deficits in HD mice. Conclusion: This study suggests that impaired CB1R function in hippocampal GABAergic interneurons contributes to memory dysfunction in HD., This work was supported by the Spanish Ministerio de Ciencia e Innovación (PID2021-123732OB-I00 to SG, PID2021-125118OB-I00 to MG, PID2019-106579RB-I00, and PID2022-142617NB-I00 to GP, and PID2022-141700OB-I00 to AB funded by MCIN/AEI/ https://doi.org/10.13039/501100011033). Fundació la Marató de TV3 (202013-30-31-32 to SG, MG and GP), AGAUR Generalitat de Catalunya (2021-SGR-01358 to AB and 2021-SGR 01086 to SG) and grants to R. R.-P. rom the Basque Government IT1454-22 to the "Neurochemistry and Neurodegeneration" consolidated research group; Instituto de Salud Carlos III through the project PI20/00153 (co-funded by European Regional Development Fund "A way to make Europe") and by BIOEF through the project BIO22/ALZ/010 funded by Eitb Maratoia. A P-V is the recipient of a PRE2022-101764 fellowship (PID2021-123732OB-I00). I.B.d.T. is the recipient of an Investigo fellowship funded by the European Union-Next Generation EU.
Docta Complutense
Publicación Artículo científico (JournalArticle)

Cannabinoid CB1 receptors drive oligodendrocyte maturation during myelin regeneration

  • Ezquerro Herce, Sara
  • Sánchez De La Torre, Aníbal
  • Monory, Krisztina
  • Lutz, Beat
  • Guzmán Pastor, Manuel
  • Aguado Sánchez, Tania
  • Palazuelos Diego, Javier
Oligodendrocytes, the myelin-producing cells in the central nervous system, derive from oligodendrocyte progenitor cells during both development and remyelination. The intricate process of oligodendrocyte differentiation, which involves several transitional stages before generating fully mature myelin-producing cells, is tightly regulated by extracellular signals. Despite advances in identifying key regulators, the comprehensive network of signaling molecules governing oligodendrocyte maturation in the healthy, and more importantly, the demyelinated brain remains incompletely understood. The endocannabinoid system has been recognized as a key regulator of oligodendroglial lineage progression, contributing to myelin formation and regeneration. In particular, CB1 cannabinoid receptors are prominent modulators of the initial steps of oligodendrocyte progenitor cell differentiation. However, the potential role of CB1 receptors in the terminal stages of oligodendrocyte differentiation remains poorly explored. Here, using a new conditional genetic mouse model in which the CB1 receptor-encoding gene was selectively ablated from differentiated oligodendrocytes, together with the cuprizone diet-induced demyelination paradigm, we demonstrate that CB1 receptors are essential for the terminal stages of oligodendroglial maturation during myelin regeneration. Specifically, we found that CB1 receptor gene inactivation in newly regenerated oligodendrocytes hinders oligodendroglial cell maturation and brain remyelination, exacerbates glial activation and axonal damage, and abolishes motor function recovery. Taken together, our findings demonstrate a crucial role for CB1 receptors in modulating oligodendrocyte maturation during myelin regeneration and supports the notion that appropriate endocannabinoid signaling in the oligodendroglial lineage is essential for achieving efficient remyelination.